Characteristics and overall survival of EGFR mutation-positive non-small cell lung cancer treated with EGFR tyrosine kinase inhibitors: a retrospective analysis for 1660 Japanese patients
Supplementary Data
Supplementary Data
Supplementary Figure 1
- doc file
Supplementary Figure 2
- doc file
Supplementary Figure 3
- doc file
Supplementary Table 1
- doc file